JP2008540398A5 - - Google Patents

Download PDF

Info

Publication number
JP2008540398A5
JP2008540398A5 JP2008509538A JP2008509538A JP2008540398A5 JP 2008540398 A5 JP2008540398 A5 JP 2008540398A5 JP 2008509538 A JP2008509538 A JP 2008509538A JP 2008509538 A JP2008509538 A JP 2008509538A JP 2008540398 A5 JP2008540398 A5 JP 2008540398A5
Authority
JP
Japan
Prior art keywords
oligosaccharide
unit
mannose
formula
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008509538A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008540398A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2006/001703 external-priority patent/WO2006120576A2/en
Publication of JP2008540398A publication Critical patent/JP2008540398A/ja
Publication of JP2008540398A5 publication Critical patent/JP2008540398A5/ja
Withdrawn legal-status Critical Current

Links

JP2008509538A 2005-05-06 2006-05-08 髄膜炎a型ワクチンのための免疫原 Withdrawn JP2008540398A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67828905P 2005-05-06 2005-05-06
PCT/IB2006/001703 WO2006120576A2 (en) 2005-05-06 2006-05-08 Immunogens for meningitidis-a vaccines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013079295A Division JP5699174B2 (ja) 2005-05-06 2013-04-05 髄膜炎a型ワクチンのための免疫原

Publications (2)

Publication Number Publication Date
JP2008540398A JP2008540398A (ja) 2008-11-20
JP2008540398A5 true JP2008540398A5 (https=) 2009-06-25

Family

ID=36942242

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008509538A Withdrawn JP2008540398A (ja) 2005-05-06 2006-05-08 髄膜炎a型ワクチンのための免疫原
JP2013079295A Expired - Fee Related JP5699174B2 (ja) 2005-05-06 2013-04-05 髄膜炎a型ワクチンのための免疫原

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013079295A Expired - Fee Related JP5699174B2 (ja) 2005-05-06 2013-04-05 髄膜炎a型ワクチンのための免疫原

Country Status (15)

Country Link
US (1) US8062641B2 (https=)
EP (1) EP1885734B1 (https=)
JP (2) JP2008540398A (https=)
CN (1) CN101282984B (https=)
AU (1) AU2006245440B2 (https=)
BR (1) BRPI0611447A2 (https=)
CA (1) CA2606890C (https=)
ES (1) ES2533248T3 (https=)
MX (1) MX2007013881A (https=)
NZ (1) NZ563940A (https=)
PL (1) PL1885734T3 (https=)
PT (1) PT1885734E (https=)
RU (1) RU2412944C2 (https=)
WO (1) WO2006120576A2 (https=)
ZA (1) ZA200710558B (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
PE20110072A1 (es) * 2005-06-27 2011-02-04 Glaxosmithkline Biolog Sa Composicion inmunogenica
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
AU2014200640B2 (en) * 2007-01-11 2016-06-16 Glaxosmithkline Biologicals Sa Modified saccharides
GB0700562D0 (en) * 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
KR101646960B1 (ko) 2007-10-16 2016-08-09 프로젠 피지500 시리즈 피티와이 리미티드 신규한 황산화된 올리고사카라이드 유도체
CN107913396B (zh) 2010-08-23 2022-03-08 惠氏有限责任公司 脑膜炎萘瑟氏菌rLP2086抗原的稳定制剂
EP2612148B1 (en) 2010-09-04 2019-06-12 GlaxoSmithKline Biologicals SA Bactericidal antibody assays to assess immunogenicity and potency of meningococcal capsular saccharide vaccines
AU2011300409B2 (en) 2010-09-10 2015-03-26 Wyeth Llc Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
CN102417521B (zh) * 2010-09-28 2014-05-07 中国医学科学院医药生物技术研究所 一种非环核苷类抗病毒药物磷酸单酯化合物的制备方法
WO2012103444A2 (en) * 2011-01-28 2012-08-02 Purdue Research Foundation Immunogenic compositions and reagents for preparing
WO2013009826A1 (en) * 2011-07-12 2013-01-17 The General Hospital Corporation Conjugating amines
RU2476444C1 (ru) * 2011-07-15 2013-02-27 Российская Федерация, от имени которой выступает Министерство промышленности и торговли Российской Федерации (Минпромторг России) СПОСОБ ПОЛУЧЕНИЯ КОНЪЮГАТА НОНА-β-(1→3)-ГЛЮКОЗИДА С БЫЧЬИМ СЫВОРОТОЧНЫМ АЛЬБУМИНОМ СКВАРАТНЫМ МЕТОДОМ
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
MY198910A (en) 2012-03-09 2023-10-02 Pfizer Neisseria meningitidis compositions and methods thereof
WO2014130613A2 (en) * 2013-02-22 2014-08-28 Amgen Inc. Carbohydrate phosphonate derivatives as modulators of glycosylation
WO2014136064A2 (en) 2013-03-08 2014-09-12 Pfizer Inc. Immunogenic fusion polypeptides
MX2016000099A (es) * 2013-07-07 2016-07-07 Max Planck Ges Zur Förderung Der Wissenschaften E V Vacunas sinteticas contra streptococcus pneumoniae tipo 1.
RU2662968C2 (ru) 2013-09-08 2018-07-31 Пфайзер Инк. Иммуногенная композиция против neisseria meningitidis (варианты)
CN106061986B (zh) * 2014-02-25 2020-07-07 默沙东和惠康基金会合资的希勒曼实验室私人有限公司 脑膜炎奈瑟菌血清组x的新的合成寡聚体及其制备方法
EA201700177A1 (ru) * 2014-10-09 2017-07-31 Мсд Уэлком Траст Хиллеман Лабораторис Пвт. Лтд. Улучшенный способ конъюгирования и полученные с помощью него новые синтетические конъюгаты олигосахарида с белком
WO2016132294A1 (en) 2015-02-19 2016-08-25 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
BR112019003992A2 (pt) 2016-09-02 2019-05-28 Sanofi Pasteur Inc vacina contra neisseria meningitidis
AU2018215585B2 (en) 2017-01-31 2022-03-17 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
WO2018173068A1 (en) * 2017-03-21 2018-09-27 Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. A novel synthetic neisseria meningitidis serogroup a oligomer and process for synthesizing thereof
CA3120451A1 (en) 2018-11-22 2020-05-28 Idorsia Pharmaceuticals Ltd Stable vaccine against clostridium difficile with modifications to the ps-ii saccharide
WO2021059181A1 (en) 2019-09-27 2021-04-01 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
CN118178643B (zh) * 2024-04-28 2024-11-29 亚培烯科技(上海)有限公司 饱和α烯烃低聚物作为佐剂在动物疫苗中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US6114309A (en) * 1997-11-21 2000-09-05 Incara Research Laboratories Combinatorial library of moenomycin analogs and methods of producing same
JP4774496B2 (ja) * 2001-06-14 2011-09-14 独立行政法人産業技術総合研究所 α−マンノシダーゼ
ES2616180T3 (es) * 2002-03-26 2017-06-09 Glaxosmithkline Biologicals Sa Sacáridos modificados con estabilidad mejorada en agua para su uso como medicamento
GB0220198D0 (en) 2002-08-30 2002-10-09 Chiron Spa Modified saccharides,conjugates thereof and their manufacture
EP2172213B1 (en) * 2003-01-30 2013-04-03 Novartis AG Injectable vaccines against multiple meningococcal serogroups
RU2250113C2 (ru) * 2003-06-04 2005-04-20 Институт биоорганической химии им. академиков М.М.Шемякина и Ю.А.Овчинникова Российской академии наук Способ приготовления бивалентной вакцины для профилактики менингококковой инфекции

Similar Documents

Publication Publication Date Title
JP2008540398A5 (https=)
RU2412944C2 (ru) Иммуногены для вакцин против менингита а
JP2013136639A5 (https=)
JP2010515718A5 (https=)
TWI633112B (zh) 醣類-醣脂類結合性疫苗
JP2010132925A5 (https=)
JP2012017342A5 (https=)
JP2005526153A5 (https=)
Enotarpi et al. A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A
CN107709343B (zh) 针对肺炎链球菌血清型5的疫苗
AU2014289342B2 (en) Synthetic vaccines against Streptococcus pneumoniae type 1
Torres‐Sanchez et al. Synthesis and biological evaluation of phosphono analogues of capsular polysaccharide fragments from Neisseria meningitidis A
Wright et al. Preparation of synthetic glycoconjugates as potential vaccines against Shigella flexneri serotype 2a disease
JPH0885703A (ja) 臓器移行性を有する多糖誘導体および薬物担体
Sukhova et al. Synthesis and preliminary immunological evaluation of a pseudotetrasaccharide related to a repeating unit of the Streptococcus pneumoniae serotype 6A capsular polysaccharide
JP4850377B2 (ja) リボース−リビトールホスフェートのオリゴ糖誘導体とそれを含むワクチン
AU2021331377B2 (en) Pentavalent vaccine against neisseria meningitidis comprising a synthetic men a antigen
CA3131741A1 (en) Carbocyclic derivatives and conjugated derivatives thereof, and their use in vaccines
JP2024180376A (ja) 化合物、免疫増強剤、ワクチン組成物及び粘膜ワクチン組成物
Auberger Synthesis of Neisseria meningitidis serogroup A carba analogues as hydrolytically stable antigens for antimeningococcal glycoconjugate vaccines
CN119095871A (zh) 预防/治疗铜绿假单胞菌感染
Koutha Synthetic studies toward pseudopentasaccharide repeating unit of Streptococcus pneumoniae zwitterionic polysaccharide